Skip to search formSkip to main content

12-hydroxyellipticine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The antineoplastic alkaloid ellipticine is a prodrug, whose pharmacological efficiency is dependent on its cytochrome P450 (P450… Expand
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Ellipticine is an antineoplastic agent considered a pro-drug, the pharmacological and genotoxic effects of which are dependent on… Expand
  • figure 3
  • table 1
  • table 3
  • table 4
Is this relevant?
2009
2009
Ellipticine is an antineoplastic agent, whose mode of action is based mainly on DNA intercalation, inhibition of topoisomerase II… Expand
  • figure 8
  • table 1
  • table 2
  • table 2
  • table 5
Is this relevant?
2009
2009
OBJECTIVES Ellipticine is a potent antineoplastic agent exhibiting multiple mechanisms of action with promising brain tumor… Expand
Is this relevant?
2007
2007
Ellipticine induces formation of two DNA adducts in leukemia HL-60 and CCRF-CEM cells, identical with deoxyguanosine adducts… Expand
Is this relevant?
2007
2007
Ellipticine is an antineoplastic agent whose mode of action is based mainly on DNA intercalation, inhibition of topoisomerase II… Expand
  • figure 1
  • table 1
  • figure 3
  • table 2
  • table 3
Is this relevant?
2007
2007
Ellipticine is an antineoplastic agent, whose mode of antitumor and/or toxic side effects is based on DNA intercalation… Expand
Is this relevant?
2006
2006
Ellipticine is an antineoplastic agent, whose mode of action is based mainly on DNA intercalation, inhibition of topoisomerase II… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Ellipticine is an antineoplastic agent, the mode of action of which is considered to be based on DNA intercalation and inhibition… Expand
  • table 1
  • table 1
  • figure 1
  • figure 4
  • figure 2
Is this relevant?